C. diff, or Clostridioides difficile, is a germ that can cause diarrhea and colitis and in some instances can be life threatening.

"But what we find that's novel is that there is a lot more movement of C. diff between surfaces, from surface-to-patient, and from patient-to-surface than previously found." By simultaneously ...

C. diff can spread covertly from surface to surface and remain undetected for weeks until it infects a patient. The results could spur more rigorous preventive measures that stop hidden spread of ...

To continue reading and help Philly news thrive, unlock this exclusive offer for unlimited digital access to Inquirer.com and ...

"But what we find that's novel is that there is a lot more movement of C. diff between surfaces, from surface-to-patient, and from patient-to-surface than previously found." Notably, the team ...

C. diff can spread covertly from surface to surface for weeks in an ICU before finally infecting a patient, and often passes between patients who aren’t in the hospital at the same time, researchers ...

C. diff can spread covertly from surface to surface for weeks in an ICU before finally infecting a patient, and often passes between patients who aren’t in the hospital at the same time ...

The researchers documented how C. diff shed from patients appeared on healthcare personnel’s hands, leaving other patient rooms during concurrent stays and on surfaces in other patient rooms ...

C. diff exposure was present in about 10% of ICU patients, either on the person’s body or in their room. In most cases, the bacteria was genetically identical to that found on another patient ...

Overall, they detected the bacteria in about 10 percent of the patients sampled — with C. diff either on a patient's body or in the room. It wasn't clear how often the bacteria was detected ...

“But what we find that’s novel is that there is a lot more movement of C. diff between surfaces, from surface-to-patient, and from patient-to-surface than previously found.” Michael Rubin, MD, PhD ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing ... of the shot compared to placebo in the 17,500-patient trial, which enrolled subjects 50 years of age ...